Modern regenerative medicine dictionary: an augmented guide to biotherapy.

Regenerative MedicineAhead of Print EditorialModern regenerative medicine dictionary: an augmented guide to biotherapyAndre TerzicAndre Terzic *Author for correspondence: Tel.: +1 507 284 5514; E-mail Address: terzic.andre@mayo.eduhttps://orcid.org/0000-0001-9210-009XMarriott Heart Disease Research Program, Department of Cardiovascular Medicine, Department of Molecular Pharmacology & Experimental Therapeutics, Department of Clinical Genomics, Mayo Clinic, Rochester, MN 55905, USASearch for more papers by this authorPublished Online:14 Nov 2023https://doi.org/10.2217/rme-2023-0200AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInRedditEmail View articleKeywords: advanced therapiesbioprintingbiotherapyglossaryhealthcare innovationinterdisciplinaryregenerationtissue engineeringReferences1. Future Science Group. Regenerative Medicine Journal. The Glossary for Advanced Therapies. Regen. Med. 18(12), 1–172 (2023).Medline, Google Scholar2. Terzic A. Regenerative medicine lexicon. Regen. Med. 15(12), 2325–2328 (2020).Link, CAS, Google Scholar3. Yamada S, Behfar A, Terzic A. Regenerative medicine clinical readiness. Regen. Med. 16(3), 309–322 (2021).Link, CAS, Google Scholar4. Califf RM, Marks PW. Biological therapies need definitive randomized controlled clinical trials. Sci. Transl. Med. 15(680), eadg2970 (2023).Crossref, Medline, Google Scholar5. Terzic A, Pfenning MA, Gores GJ, Harper CM Jr. Regenerative medicine build-out. Stem Cells Transl. Med. 4(12), 1373–1379 (2015).Crossref, Medline, Google Scholar6. Terzic A, Harper CM Jr, Gores GJ, Pfenning MA. Regenerative medicine blueprint. Stem Cells Dev. 22(Suppl. 1), 20–24 (2013).Crossref, Medline, Google Scholar7. Terzic A, Nelson TJ. Regenerative medicine primer. Mayo Clin. Proc. 88(7), 766–775 (2013).Crossref, Medline, Google Scholar8. Nelson TJ, Behfar A, Terzic A. Strategies for therapeutic repair: the “R3” regenerative medicine paradigm. Clin. Transl. Sci. 1, 168–171 (2008).Crossref, Medline, Google Scholar9. Behfar A, Terzic A. Regeneration for all: An Odyssey in biotherapy. Eur. Heart J. 40(13), 1033–1035 (2019).Crossref, Medline, Google Scholar10. Wyles SP, Terzic A. Building the regenerative medicine workforce of the future: an educational imperative. Regen. Med. 14(7), 613–615 (2019).Link, CAS, Google Scholar11. Wyles SP, Hayden RE, Meyer FB, Terzic A. Regenerative medicine curriculum for next-generation physicians. NPJ Regen. Med. 4, 3 (2019).Crossref, Medline, Google Scholar12. Hargraves IG, Behfar A, Foxen JL, Montori VM, Terzic A. Towards regeneration: the evolution of medicine from fighting to building. BMJ 361, k1586 (2018).Crossref, Google Scholar13. Plackett B. Cells or drugs? The race to regenerate the heart. Nature 594, S16–S17 (2021).Crossref, CAS, Google Scholar14. Zhang K, Cheng K. Stem cell-derived exosome versus stem cell therapy. Nat. Rev. Bioeng. doi: 10.1038/s44222-023-00064-2 (2023) (Epub ahead of print).Crossref, Google Scholar15. McKinley KL, Longaker MT, Naik S. Emerging frontiers in regenerative medicine. Science 380(6647), 796–798 (2023).Crossref, Medline, CAS, Google Scholar16. Kimbrel EA, Lanza R. Next-generation stem cells – ushering in a new era of cell-based therapies. Nat. Rev. Drug Discov. 19, 463–479 (2020).Crossref, Medline, CAS, Google Scholar17. Terzic A, Waldman SA. Chronic diseases: the emerging pandemic. Clin. Transl. Sci. 4(3), 225–226 (2011).Crossref, Medline, Google Scholar18. Garmany A, Yamada S, Terzic A. Longevity leap: mind the healthspan gap. NPJ Regen. Med. 6(1), 57 (2021).Crossref, Medline, CAS, Google Scholar19. Wells JM, Watt FM. Diverse mechanisms for endogenous regeneration and repair in mammalian organs. Nature 557(7705), 322–328 (2018).Crossref, Medline, CAS, Google Scholar20. Selvam A, Aggarwal T, Mukherjee M, Verma YK. Humans and robots: friends of the future? A bird's eye view of biomanufacturing industry 5.0. Biotechnol. Adv. 68, 108237 (2023).Crossref, Medline, Google Scholar21. Magalhaes RS, Williams JK, Yoo KW, Yoo JJ, Atala A. A tissue-engineered uterus supports live births in rabbits. Nat. Biotechnol. 38(11), 1280–1287 (2020).Crossref, Medline, CAS, Google Scholar22. Fioretta ES, Motta SE, Lintas V et al. Next-generation tissue-engineered heart valves with repair, remodelling and regeneration capacity. Nat. Rev. Cardiol. 18(2), 92–116 (2021).Crossref, Medline, Google Scholar23. Pașca SP, Arlotta P, Bateup HS et al. A nomenclature consensus for nervous system organoids and assembloids. Nature 609(7929), 907–910 (2022).Crossref, Medline, CAS, Google Scholar24. Yamada S, Bartunek J, Behfar A, Terzic A. Mass customized outlook for regenerative heart failure care. Int. J. Mol. Sci. 22(21), 11394 (2021).Crossref, Medline, CAS, Google Scholar25. Yamada S, Jeon R, Garmany A, Behfar A, Terzic A. Screening for regenerative therapy responders in heart failure. Biomark. Med. 15(10), 775–783 (2021).Link, CAS, Google Scholar26. Marks PW, Hahn S. Identifying the risks of unproven regenerative medicine therapies. JAMA 324(3), 241–242 (2020).Crossref, Medline, Google Scholar27. Cossu G, Fears R, Griffin G, Ter Meulen V. Regenerative medicine: challenges and opportunities. Lancet 395(10239), 1746–1747 (2020).Crossref, Medline, Google Scholar28. Leask F, Terzic A. Regenerative outlook: offering global solutions for equitable care. Regen. Med. 15(11), 2249–2252 (2020).Link, CAS, Google Scholar29. Webster A, Terzic A. Regenerative readiness: innovation meets sociology. Regen. Med. 16(3), 189–195 (2021).Link, CAS, Google Scholar30. Yamanaka S. Ekiden to iPS cells. Nat. Med. 15(10), 1145–1148 (2009).Crossref, Medline, CAS, Google ScholarFiguresReferencesRelatedDetails Ahead of Print STAY CONNECTED Metrics Downloaded 0 times History Received 13 October 2023 Accepted 16 October 2023 Published online 14 November 2023 Information© 2023 Future Medicine LtdKeywordsadvanced therapiesbioprintingbiotherapyglossaryhealthcare innovationinterdisciplinaryregenerationtissue engineeringAcknowledgmentsThe author recognizes the Marriott Family Foundation for invaluable support in advancing the principles and practices of regenerative medicine. A Terzic is a Mayo Clinic Distinguished Investigator.Financial disclosureA Terzic acknowledges the National Institutes of Health grant award (R01 HL134664). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.Competing interest disclosureA Terzic is a co-inventor on regenerative sciences related intellectual property disclosed to Mayo Clinic. Mayo Clinic and A Terzic have interests in Rion LLC. The authors have no other competing interests or relevant affiliations with any organization or entity with the subject matter or materials discussed in the manuscript apart from those disclosed.Writing disclosureNo writing assistance was utilized in the production of this manuscript.PDF download